LHC
ABBV icon

Little House Capital’s AbbVie ABBV Stock Holding History

Little House Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,166
Closed -$996K – 106
2022
Q4 		$996K Buy
6,166
+201
+3% +$30.8K 0.49% 53
2022
Q3 		$801K Buy
5,965
+168
+3% +$24.1K 0.43% 63
2022
Q2 		$888K Sell
5,797
-1,643
-22% -$251K 0.48% 57
2022
Q1 		$1.21M Buy
7,440
+1,803
+32% +$262K 0.62% 56
2021
Q4 		$763K Buy
5,637
+224
+4% +$26.5K 0.4% 70
2021
Q3 		$584K Sell
5,413
-570
-10% -$65.1K 0.34% 84
2021
Q2 		$674K Buy
5,983
+4,008
+203% +$451K 0.36% 85
2021
Q1 		$213K Sell
1,975
-8,062
-80% -$862K 0.08% 98
2020
Q4 		$1.07M Buy
10,037
+5,030
+100% +$483K 0.79% 47
2020
Q3 		$438K Buy
5,007
+1,315
+36% +$124K 0.36% 70
2020
Q2 		$362K Buy
+3,692
New +$325K 0.33% 73
2019
Q2 		– Sell
-200
Closed -$16K – 108
2019
Q1 		$16K Buy
+200
New +$16.4K 0.01% 222

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Little House Capital's ABBV Position: Q1 2023 in Review

Little House Capital sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 6,166 shares — an estimated $996K sold.

Little House Capital first reported a position in ABBV in Q1 2019 and held it in 12 quarters. The position peaked at $1.21M in Q1 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Little House Capital reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Little House Capital sold 6,166 AbbVie shares in Q1 2023, an estimated $996K.
  • Little House Capital first reported a position in AbbVie in Q1 2019 and held it in 12 quarters.
  • Little House Capital's AbbVie position peaked at $1.21M in Q1 2022.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Little House Capital's 13F filing for Q1 2023, filed 4 May 2023.